Positive 9 Month Results From BIOFLOW-II Clinical Trial and 12 Month Results From BIOFLOW-III Registry Presented at EuroPCR Congress
BUELACH, SWITZERLAND–(Marketwired – May 31, 2013) – Primary end-point results from the BIOFLOW-II Clinical Study demonstrating the non-inferiority of the BIOTRONIK Orsiro Hybrid …
برلين–(Marketwire – 18 فبراير 2013) – أعلنت اليوم BIOTRONIK (بيوترونيك) الرائدة في مجال تصنيع التقنيات الطبية لمرضى القلب في أعقاب احتفالها بالذكرى السنوية رقم 50 في عام 2013 عن حصول أجهزة Ilesto 7 الخاصة بإزالة الرجفان القابلة للزرع/ وأجهزة إزالة الرجفان …
BERLIN–(Marketwire – February 15, 2013) – BIOTRONIK, the leading manufacturer of cardiovascular medical technology that is celebrating its 50th anniversary in 2013, announced today that the Ilesto 7 implantable cardioverter-defibrillator/car
BIOTRONIK Renews Commitment After Achieving Their First Milestone of Providing 1,000 Life Saving Devices One Year Earlier Than Expected
BERLIN–(Marketwire – October 1, 2012) – BIOTRONIK, a leading manufacturer of innovative medical technology, has surpassed its commitment to provide life-saving devices …
BERLIN–(Marketwire – September 10, 2012) – Female electrophysiologists from around the world gathered on August 28th, 2012 at the European Society of Cardiology Congress to attend the EPIC Alliance’s scientific session: “The Heart of the Matter.”
The EPIC Alliance (Electrophysiologist International Community …
